Simplex Trading’s Foundation Medicine, Inc. FMI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-5,378
| Closed | -$488K | – | 8269 |
|
|
2018
Q1 | $423K | Buy |
+5,378
| New | +$397K | 0.02% | 799 |
|
|
2017
Q4 | – | Sell |
-3,987
| Closed | -$207K | – | 7191 |
|
|
2017
Q3 | $160K | Buy |
3,987
+3,041
| +321% | +$117K | 0.01% | 1350 |
|
|
2017
Q2 | $37K | Buy |
+946
| New | +$34.6K | ﹤0.01% | 2685 |
|
|
2017
Q1 | – | Sell |
-3,452
| Closed | -$86.1K | – | 7218 |
|
|
2016
Q4 | $61K | Sell |
3,452
-5,886
| -63% | -$127K | ﹤0.01% | 1972 |
|
|
2016
Q3 | $218K | Buy |
9,338
+2,931
| +46% | +$66.5K | 0.01% | 972 |
|
|
2016
Q2 | $119K | Buy |
6,407
+4,684
| +272% | +$84.7K | 0.01% | 1358 |
|
|
2016
Q1 | $31K | Sell |
1,723
-14,260
| -89% | -$230K | ﹤0.01% | 2412 |
|
|
2015
Q4 | $336K | Buy |
15,983
+9,344
| +141% | +$180K | 0.03% | 591 |
|
|
2015
Q3 | $122K | Buy |
6,639
+4,740
| +250% | +$118K | 0.01% | 1267 |
|
|
2015
Q2 | $64K | Sell |
1,899
-5,615
| -75% | -$226K | 0.01% | 1522 |
|
|
2015
Q1 | $361K | Buy |
7,514
+1,682
| +29% | +$76.3K | 0.04% | 440 |
|
|
2014
Q4 | $130K | Buy |
+5,832
| New | +$135K | 0.02% | 796 |
|
Simplex Trading's FMI Position: Q2 2018 in Review
Simplex Trading sold out of Foundation Medicine, Inc. (FMI) in Q2 2018, closing a stake of 5,378 shares — an estimated $488K sold.
Simplex Trading first reported a position in FMI in Q4 2014 and held it in 12 quarters. The position peaked at $423K in Q1 2018. 157 funds tracked by Wall St. Rank hold FMI as of Q2 2018.
- Simplex Trading reported no remaining Foundation Medicine, Inc. position as of Q2 2018 after selling out during the quarter.
- Simplex Trading sold 5,378 Foundation Medicine, Inc. shares in Q2 2018, an estimated $488K.
- Simplex Trading first reported a position in Foundation Medicine, Inc. in Q4 2014 and held it in 12 quarters.
- Simplex Trading's Foundation Medicine, Inc. position peaked at $423K in Q1 2018.
- 157 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q2 2018.
Based on Simplex Trading's 13F filing for Q2 2018, filed 30 Jul 2018.